Header
Dataemia
Menu
Search for
Switch skin
Latest News
Cardiology
Dentistry
Surgery/Cosmetic
Neurology
AI/ML
Pharma / Biotech
Pediatrics
Biology
Gastroenterology
COVID-19 Live Stats
CPHQ
Informatics
Research
Privacy Policy
Disclaimer
Contact US
Search for
Switch skin
Sidebar
Random Article
LinkedIn
Twitter
Facebook
Header
UGT1A
Gastroenterology
December 26, 2018
135
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype
Back to top button
Close
Search for
Close
Search for